Biostar Microtech International Corp.

TWSE:2399 Stock Report

Market Cap: NT$5.6b

Biostar Microtech International Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Biostar Microtech International.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Tech earnings growth18.5%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Biostar Microtech International Corp.'s (TWSE:2399) 27% Share Price Plunge Could Signal Some Risk

Nov 15
Biostar Microtech International Corp.'s (TWSE:2399) 27% Share Price Plunge Could Signal Some Risk

Biostar Microtech International Corp. (TWSE:2399) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Sep 16
Biostar Microtech International Corp. (TWSE:2399) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

The Biostar Microtech International (TPE:2399) Share Price Is Up 93% And Shareholders Are Holding On

Feb 11
The Biostar Microtech International (TPE:2399) Share Price Is Up 93% And Shareholders Are Holding On

We're Not So Sure You Should Rely on Biostar Microtech International's (TPE:2399) Statutory Earnings

Dec 20
We're Not So Sure You Should Rely on Biostar Microtech International's (TPE:2399) Statutory Earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biostar Microtech International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TWSE:2399 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20242,269-116-25-23N/A
3/31/20242,282-107-118-116N/A
12/31/20232,344-1132829N/A
9/30/20232,288-24-75-73N/A
6/30/20232,2843457N/A
3/31/20232,2361-84-82N/A
12/31/20222,23613-83-81N/A
9/30/20222,591143-34-33N/A
6/30/20222,726169-22-21N/A
3/31/20222,870331115117N/A
12/31/20212,7753628992N/A
9/30/20212,510311-46-44N/A
6/30/20212,517339-62-59N/A
3/31/20212,284239-133-132N/A
12/31/20202,105138-96-93N/A
9/30/20201,9511282536N/A
6/30/20201,69424114127N/A
3/31/20201,631-92289312N/A
12/31/20191,673-71304328N/A
9/30/20191,779-221233259N/A
6/30/20192,045-41570110N/A
3/31/20192,462-329-279-209N/A
12/31/20183,040-243-189-85N/A
9/30/20183,305-124-317-202N/A
6/30/20183,441147-232-132N/A
3/31/20183,701211N/A65N/A
12/31/20173,443100N/A-208N/A
9/30/20173,364113N/A-47N/A
6/30/20173,3008N/A-107N/A
3/31/20172,998-47N/A61N/A
12/31/20162,998-33N/A220N/A
9/30/20162,793-99N/A587N/A
6/30/20162,915-38N/A692N/A
3/31/20162,902-114N/A682N/A
12/31/20152,831-104N/A479N/A
9/30/20152,939-199N/A138N/A
6/30/20153,188-198N/A-165N/A
3/31/20153,604-134N/A-652N/A
12/31/20144,151-66N/A-400N/A
9/30/20144,699120N/A-519N/A
6/30/20144,671108N/A-170N/A
3/31/20144,702123N/A175N/A
12/31/20134,609123N/A189N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 2399's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if 2399's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 2399's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 2399's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 2399's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 2399's Return on Equity is forecast to be high in 3 years time


Discover growth companies